[HTML][HTML] Recent advances of sonodynamic therapy in cancer treatment
…, Y Liu, BW Chen, YY Liu, YS Wang… - Cancer biology & …, 2016 - ncbi.nlm.nih.gov
Sonodynamic therapy (SDT) is an emerging approach that involves a combination of low-intensity
ultrasound and specialized chemical agents known as sonosensitizers. Ultrasound …
ultrasound and specialized chemical agents known as sonosensitizers. Ultrasound …
Self-aggregated nanoparticles of cholesterol-modified chitosan conjugate as a novel carrier of epirubicin
YS Wang, LR Liu, Q Jiang, QQ Zhang - European Polymer Journal, 2007 - Elsevier
Cholesterol-modified chitosan conjugate with succinyl linkages (CHCS) was synthesized and
characterized by fourier transform infrared (FTIR) and proton nuclear magnetic resonance …
characterized by fourier transform infrared (FTIR) and proton nuclear magnetic resonance …
Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells
J Wu, Y Wang, X Yang, Y Liu, J Yang, R Yang… - …, 2012 - iopscience.iop.org
This study evaluates the reversal effects of graphene oxide (GO) used as a carrier for
adriamycin (ADR) in cancer drug resistance, and provides a preliminary investigation into the …
adriamycin (ADR) in cancer drug resistance, and provides a preliminary investigation into the …
Preparation and physicochemical characteristics of self-assembled nanoparticles of deoxycholic acid modified-carboxymethyl curdlan conjugates
FP Gao, HZ Zhang, LR Liu, YS Wang, Q Jiang… - Carbohydrate …, 2008 - Elsevier
Various deoxycholic acid (DOCA)-modified-carboxymethylated (CM)-curdlan (DCMC) were
synthesized and characterized by FTIR, 1 H NMR and XRD. The degree of DOCA …
synthesized and characterized by FTIR, 1 H NMR and XRD. The degree of DOCA …
Self-assembled nanoparticles of cholesterol-modified O-carboxymethyl chitosan as a novel carrier for paclitaxel
Y Wang, Q Jiang, R Li, L Liu, Q Zhang, Y Wang… - …, 2008 - iopscience.iop.org
Self-assembled nanoparticles of cholesterol-modified O-carboxymethyl chitosan (CCMC)
were prepared to be used as a novel carrier for paclitaxel (PTX) in this study. CCMC-6.9 was …
were prepared to be used as a novel carrier for paclitaxel (PTX) in this study. CCMC-6.9 was …
[HTML][HTML] Shikonin and 4-hydroxytamoxifen synergistically inhibit the proliferation of breast cancer cells through activating apoptosis signaling pathway in vitro and in …
HY Lin, HW Han, YS Wang, DL He, WX Sun, L Feng… - Chinese medicine, 2020 - Springer
Background Tamoxifen (TAM) is a cell type-specific anti-estrogen and is applied to improve
the survival of patients with estrogen receptor positive (ER +) breast cancer. However, long-…
the survival of patients with estrogen receptor positive (ER +) breast cancer. However, long-…
Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin
…, F Gao, H Tang, Y Bai, R Li, X Li, L Liu, Y Wang… - …, 2010 - iopscience.iop.org
The purpose of this study was to develop nanoparticles made of cholesterol-conjugated
carboxymethyl curdlan (CCMC) entrapping epirubicin (EPB) and establish their in vitro and in …
carboxymethyl curdlan (CCMC) entrapping epirubicin (EPB) and establish their in vitro and in …
Design, synthesis and biological evaluation of benzoylacrylic acid shikonin ester derivatives as irreversible dual inhibitors of tubulin and EGFR
…, ZL Wen, YS Wang, JY Fu, YT Lu, MY Wang… - Bioorganic & Medicinal …, 2019 - Elsevier
In this study, a series of shikonin derivatives combined with benzoylacrylic had been designed
and synthesized, which showed an inhibitory effect on both tubulin and the epidermal …
and synthesized, which showed an inhibitory effect on both tubulin and the epidermal …
Self-aggregated nanoparticles of cholesterol-modified pullulan conjugate as a novel carrier of mitoxantronep
…, M Zhang, Q Zhang, L Liu, Q Jiang, Y Wang - Current …, 2010 - ingentaconnect.com
Cholesterol-modified pullulan (CHSP) conjugate with succinyl linkages was synthesized
and characterized by fourier transform infrared (FT-IR), proton nuclear magnetic resonance (1H …
and characterized by fourier transform infrared (FT-IR), proton nuclear magnetic resonance (1H …
Stability and in vivo evaluation of pullulan acetate as a drug nanocarrier
…, ZM Zhou, HL Chen, XM Li, LR Liu, YS Wang… - Drug Delivery, 2010 - Taylor & Francis
To develop pullulan acetate nanoparticles (PANs) as a drug nanocarrier, pullulan acetate (PA)
was synthesized and characterized. Its acetylation degree determined by the proton …
was synthesized and characterized. Its acetylation degree determined by the proton …